At EMUNO, we develop new drugs to control immunity, treat diseases, and enhance human health and wellbeing. We design and apply superior identification and optimization strategies tailored for each individual target. This allows us to create therapeutics that promote or dampen specific immune responses, such as to treat autoimmune disorders or overcome cancer immune evasion.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Freiburg I. Brsg., De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.emuno.com/
- Keywords
- goodBot.
- HQ
- Freiburg i. Brsg.
Emuno Therapeutics Gmbh Questions
Emuno Therapeutics Gmbh's website is https://www.emuno.com/
Emuno Therapeutics Gmbh's LinkedIn profile is https://de.linkedin.com/company/emuno
Emuno Therapeutics Gmbh has
5 employees.
View email and phone details for 5
employees at Emuno Therapeutics Gmbh.
Emuno Therapeutics Gmbh's industry is
Biotechnology Research
Emuno Therapeutics Gmbh's top competitors are
Gründungsbüro Der Albert-Ludwigs-Universität Freiburg,
Umlaut.bio Gmbh,
Abbvie,
Biolabs Heidelberg,
Goodbot,
Biorizon Consulting,
Boehringer Ingelheim,
Cptx,
Heidelberg Epignostix Gmbh,
Panosome Gmbh.
Emuno Therapeutics Gmbh's categories are Biotechnology Research
Emuno Therapeutics Gmbh's founding year is 2024
